c Cytolysin and gelatinase are prominent pathogenicity determinants associated with highly virulent Enterococcus faecalis strains. In an effort to explore the expression profiles of these virulence traits in vivo, we have employed E. faecalis variants expressing the luxABCDE cassette under the control of either the P 16S , cytolysin, or gelatinase promoter for infections of Galleria mellonella caterpillars and mice. Systemic infection of G. mellonella with bioluminescence-tagged E. faecalis MMH594 revealed temporal regulation of both gelatinase and cytolysin promoters and demonstrated that these traits were induced in response to the host environment. Gavage of mice pretreated perorally with antibiotics resulted in efficient colonization of the murine gastrointestinal tract (GIT) in a strain-dependent manner, where the commensal baby isolate EF62 was more persistent than the nosocomial isolate MMH594. A highly significant correlation (R 2 > 0.94) was found between bioluminescence and the CFU counts in mouse fecal samples. Both strains showed similar preferences for growth and persistence in the ileum, cecum, and colon. Cytolysin expression was uniform in these compartments of the intestinal lumen. In spite of high numbers (10 9 CFU/g of intestinal matter) in the ileum, cecum, and colon, no evidence of translocation or systemic infection could be observed. In the murine intravenous infection model, cytolysin expression was readily detected in the liver, kidneys, and bladder. At 72 h postinfection, the highest bacterial loads were found in the liver, kidneys, and spleen, with organ-specific expression levels of cytolysin ϳ400-and ϳ900-fold higher in the spleen and heart, respectively, than in the liver and kidneys. Taken together, this system based on the bioluminescence imaging technology is established as a new, powerful method to monitor the differential regulation of E. faecalis virulence determinants and to study the spatiotemporal course of infection in living animals in real time.
Generally described as part of the indigenous flora that inhabits the mammalian gastrointestinal tract (GIT), Enterococcus faecalis has emerged in the last decades as a leading pathogenic agent associated with hospital-acquired diseases, including urinary tract, blood, endocardial, and surgical wound infections (1). In an effort to gain new insights into enterococcal infection prevention and treatment, several studies have investigated and dissected the virulence machinery of this opportunistic microorganism, revealing a number of pathogenicity determinants displaying a higher incidence in clinical isolates (2). These pathogenicity determinants include the toxin cytolysin Cyl, the serine protease SprE, and the protease gelatinase GelE, extensively examined in vitro and in vivo infection models (3, 4). Cyl is a two-peptide lantibiotic cytolytic toxin with the ability to lyse eukaryotic cells and is also capable of acting as a bacteriocin against a broad spectrum of Gram-positive bacteria. Exotoxin synthesis and maturation involve t...